Nascent Medical, LLC

Nascent Medical, LLC Medical communications company specializing in creating continuing medical education, sales and MSL training materials, and scientific/medical content.

Nascent Medical, LLC, is a US-based medical and scientific content development company that serves the e-learning, instructional design, medical publishing, and communications industries. We publish the HittList medical writing jobs list and offer the 6-week course “Everything you Need to Know to Start Your Freelance Medical Writing Business”

New FDA Approvals : Leqselvi for Alopecia Areata, Femlyv Dissolvable Birth Control, Brineura for Batten Disease, Erzofri...
07/29/2024

New FDA Approvals : Leqselvi for Alopecia Areata, Femlyv Dissolvable Birth Control, Brineura for Batten Disease, Erzofri for Schizophrenia, Eque-cel for MS, Spravato for TRD, ZW191 Anti-Tumor Agent

Use AI to Speed up Your Work Flow Ethically and Securely. There are lots of courses on AI out there, but this one is specific only to medical writing and editing.  Access the AIMWE course waitlist. Leqselvi for Alopecia Areata: The FDA has approved deuruxolitinib (Leqselvi) as a first-line trea...

New FDA Approvals : Voquenza for GERD, ADI-270 for Clear Cell Renal Cell Carcinoma, Lomecel-B in AD, ART26.12 for Chemot...
07/22/2024

New FDA Approvals : Voquenza for GERD, ADI-270 for Clear Cell Renal Cell Carcinoma, Lomecel-B in AD, ART26.12 for Chemotherapy-Induced Peripheral Neuropathy, Test for Candida auris, Botensilimab/balstilimab in mCRC

Visit to uplevel your writing and editing skills with free downloads on medical writing and editing. The FDA has approved vonoprazan (Voquenza) for treating non-erosive gastroesophageal reflux disease (GERD) in adults. Vonoprazan is an oral potassium-competitive acid blocker (PCAB) already approved....

New FDA Approvals : Blincyto for B-ALL, Zorvye for Atopic Dermatitis, Vabysmo Pre-filled Syringe, OX124 for Opioid Overd...
07/15/2024

New FDA Approvals : Blincyto for B-ALL, Zorvye for Atopic Dermatitis, Vabysmo Pre-filled Syringe, OX124 for Opioid Overdose Reversal, Voquezna for GERD

Visit for free downloads in writing in medicine and the life sciences.    The FDA has approved blinatumomab (Blincyto) for treating adult and pediatric patients one month or older with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia (B-ALL) i...

New FDA Approvals : Kisunla for Alzheimer’s, Sirturo for TB, Kar-XT for Schizophrenia, M**A-based Therapy for PTSD, Sela...
07/08/2024

New FDA Approvals : Kisunla for Alzheimer’s, Sirturo for TB, Kar-XT for Schizophrenia, M**A-based Therapy for PTSD, Seladelpar for PBC, TransCon PTH for Hypoparathyroidism, Afami-Cel for Synovial Sarcoma

Visit for free downloads and free courses related to writing in medicine and science.  - The FDA has approved donanemab (Kisunla) for early symptomatic Alzheimer's disease, making it the third drug in a new class aimed at slowing cognitive decline in early-stage patients. Eli Lilly will make th...

New FDA Approvals : Ohtuvayre for COPD, Tepylute for Breast and Ovarian Cancer, Epkinly for R/R FL, Sofdra for Primary A...
07/01/2024

New FDA Approvals : Ohtuvayre for COPD, Tepylute for Breast and Ovarian Cancer, Epkinly for R/R FL, Sofdra for Primary Axillary Hyperhidrosis, Wakix for Narcolepsy, PiaSky for PNH, Efgartigimod for CIDP, IBI343 for Pancreatic Cancer

Do you work for a CME company that needs urgent medical writing assistance? We can help. Visit - The FDA has approved ensifentrine (Ohtuvayre) as an inhaled maintenance therapy for adults with COPD. Ohtuvayre is the first new mechanism of action for COPD treatment in over two decades, offering anti-...

New FDA Approvals : Capvaxive Pneumococcal Conjugate Vaccine, Elevidys for DMD, Krazati for CRC, Keytruda for Endometria...
06/24/2024

New FDA Approvals : Capvaxive Pneumococcal Conjugate Vaccine, Elevidys for DMD, Krazati for CRC, Keytruda for Endometrial Cancer, Skyrizi for UC, Tremfya for Crohn’s Disease

Visit for the full writup of this episode and medical writing assistance.  Visit for free downloads directed towards medical writing and editing. • The FDA has approved the 21-valent pneumococcal conjugate vaccine, CAPVAXIVE™ (Merck), for the prevention of invasive disease and pneumonia in ...

New FDA Approvals : Adbry for Atopic Dermatitis, Augtyro for NTRK Tumors, Donanemab for Alzheimer's, Iqirvo for Primary ...
06/17/2024

New FDA Approvals : Adbry for Atopic Dermatitis, Augtyro for NTRK Tumors, Donanemab for Alzheimer's, Iqirvo for Primary Biliary Cholangitis, Retevmo in Thyroid Cancer, OTC Continuous Glucose Monitors

Check out for medical writing assistance. visit for free downloads on medical writing and editing Adbry for Atopic Dermatitis The FDA has approved tralokinumab-ldrm (Adbry) as a 300 mg single-dose autoinjector for moderate-to-severe atopic dermatitis (AD) in adults, offering a more convenient d...

New FDA Approvals : Klisyri for Actinic Keratosis, M**A for PTSD, Arexvy for RSV, Rytelo for MDS, Firdapse for LEMS
06/10/2024

New FDA Approvals : Klisyri for Actinic Keratosis, M**A for PTSD, Arexvy for RSV, Rytelo for MDS, Firdapse for LEMS

for medical writing assistance for your company. Visit for free downloads on medical writing and editing Klisyri for Actinic Keratosis: The FDA has approved tirbanibulin (Klisyri) for treating actinic keratosis (AK) on larger areas of the face or scalp, up to 100 cm². Previously approved for areas ...

New FDA Approvals : mRESVIA for Lower Respiratory Tract Disease, Breyanzi for R/R MCL, Sarclisa for ND MM, Onyda XR for ...
06/03/2024

New FDA Approvals : mRESVIA for Lower Respiratory Tract Disease, Breyanzi for R/R MCL, Sarclisa for ND MM, Onyda XR for ADHD, Bkemv for PNH and aHUS, Austedo in Huntington’s

Go  for complete show notes.   Visit for free downloads on medical writing and editing for medical writing assistance for your company.   mRESVIA for Lower Respiratory Tract Disease The FDA approved mRNA-1345 (mRESVIA) for preventing RSV-caused lower respiratory tract diseas...

New FDA Approvals : Imdelltra for EC-SCLC, Breyanzi for R/R LL, SNB-101 for SCLC, Upstaza for AADC Deficiency, Altuviiio...
05/20/2024

New FDA Approvals : Imdelltra for EC-SCLC, Breyanzi for R/R LL, SNB-101 for SCLC, Upstaza for AADC Deficiency, Altuviiio for Hemophilia A Label Update, Self-Collected Sample for Cervical Cancer Screening, Clinolipid Parenteral Nutrition

            For medical writing assistance, please visit for the AI in Medical Writing and Editing: Blueprint for Success in a Changing World course to assist with implementing AI in medical writing.  •    Imdelltra for EC-SCLC: The FDA granted acc...

New FDA Approvals : mRNA Anti-EBV Cancer Vaccine, BTX-9341 for Breast Cancer, Nivolumab Hyaluronidase Formulation, ColoS...
05/13/2024

New FDA Approvals : mRNA Anti-EBV Cancer Vaccine, BTX-9341 for Breast Cancer, Nivolumab Hyaluronidase Formulation, ColoSense Colorectal Cancer Screening Test

Visit for medical writing assistance. Visit for information on AI in Medical Writing and Editing - **mRNA Anti-EBV Cancer Vaccine**: The novel mRNA therapeutic cancer vaccine WGc-043 has been approved for clinical trials by the FDA, targeting Epstein-Barr virus (EBV) related cancers such as nasophar...

New FDA Approvals : 49 — Ingrezza Sprinkles for Huntington’s, Tivdak for Cervical Cancer, Xolremdi for WHIM, Esprit Sten...
05/06/2024

New FDA Approvals : 49 — Ingrezza Sprinkles for Huntington’s, Tivdak for Cervical Cancer, Xolremdi for WHIM, Esprit Stent for CLTI-BTK

Please visit for medical writing assistance for your company. Visit for free downloads on medical writing and editing Ingrezza for Huntington’s: The FDA has approved valbenazine (INGREZZA® SPRINKLE) capsules for adults with tardive dyskinesia and chorea associated with Huntington's disease. ...

Address

Jacksonville Beach, FL
32250

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm
Saturday 9am - 5pm
Sunday 9am - 5pm

Alerts

Be the first to know and let us send you an email when Nascent Medical, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Nascent Medical, LLC:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram